Skip to the page

Data / Drug companies / Norepinephrine bitartrate

Norepinephrine bitartrate: 25 companies and 37 products in the FDA NDC directory

Norepinephrine bitartrate is listed in the FDA National Drug Code Directory by 25 companies, with 37 products in commercial distribution. 22 of the products (59.5%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution, concentrate; injection, solution; injection, and the newest product started marketing on October 30, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
25
Products
37
Generic (ANDA) products
22 (59.5%)
Application numbers
17
Routes
Intravenous
Brand names
Norepinephrine, Levophed
openFDA record search
api.fda.gov

Companies that list norepinephrine bitartrate

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Baxter Healthcare Corporation6injection, solutionNew drug applications (NDA)November 21, 2023
WG Critical Care, LLC4injection, solutionNew drug applications (NDA)September 15, 2022
Long Grove Pharmaceuticals, LLC3solutionNew drug applications (NDA)February 2, 2024
Hospira, Inc.2injection, solution, concentrateNew drug applications (NDA)March 11, 2024
NorthStar RxLLC2injection; injection, solution, concentrateGeneric drugs (ANDA)October 30, 2026
Anthea Pharma Private Limited1injection, solution, concentrateGeneric drugs (ANDA)November 25, 2025
Avenacy, LLC1injection, solutionGeneric drugs (ANDA)February 1, 2026
Baxter Healthcare Corporation1injectionGeneric drugs (ANDA)May 6, 2021
Be Pharmaceuticals Inc.1injectionGeneric drugs (ANDA)December 30, 2023
Biocon Pharma Inc.1injection, solution, concentrateGeneric drugs (ANDA)July 1, 2025
Breckenridge Pharmaceutical, Inc.1injection, solution, concentrateGeneric drugs (ANDA)July 1, 2021
Camber Pharmaceuticals, Inc.1injection, solution, concentrateGeneric drugs (ANDA)January 31, 2025
Caplin Steriles Limited1injectionGeneric drugs (ANDA)September 28, 2024
Civica, Inc.1injection, solution, concentrateGeneric drugs (ANDA)March 12, 2021
Fresenius Kabi USA, LLC1solutionGeneric drugs (ANDA)March 1, 2021
Fresenius Kabi USA, LLC1solutionGeneric drugs (ANDA)March 1, 2021
Gland Pharma Limited1injectionGeneric drugs (ANDA)May 12, 2021
HF Acquisition Co LLC, DBA HealthFirst1injectionGeneric drugs (ANDA)August 8, 2021
Hikma Pharmaceuticals USA Inc.1injectionGeneric drugs (ANDA)August 1, 2018
Meitheal Pharmaceuticals Inc.1injection, solution, concentrateGeneric drugs (ANDA)December 1, 2024
Mylan Institutional LLC1injection, solution, concentrateGeneric drugs (ANDA)October 15, 2018
Novadoz Pharmaceuticals LLC1injection, solution, concentrateGeneric drugs (ANDA)December 11, 2025
Rising Pharma Holdings, Inc.1injectionGeneric drugs (ANDA)November 1, 2024
Sagent Pharmaceuticals1injection, solutionGeneric drugs (ANDA)July 1, 2021
Sandoz Inc1injection, solution, concentrateGeneric drugs (ANDA)April 23, 2019

Dosage forms

Dosage formProductsShare
Injection, solution, concentrate1232.4%
Injection, solution1232.4%
Injection821.6%
Solution513.5%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)2259.5%
New drug applications (NDA)1540.5%

Pharmacologic classes

ClassProducts
Catecholamine37

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.